Published in Pain and Central Nervous System Week, October 17th, 2005
The study will be performed by MPI's Center for Applied GenoTyping (CAGT) with two experimental goals: 1) to identify genetic variations that potentially predispose individuals to specific disorders such as depression and anxiety; and 2) further determine the impact of genetic variants on disease pathogenesis and response to psychotropic drugs.
In the first phase of the project, the MPI researchers, headed by Florian Holsboer,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week